CS logo
small CS logo
Boehringer Ingelheim Pharmaceuticals Inc

Ridgefield, Connecticut, United States
Pharmaceutical company in Ridgefield, Connecticut
900 Ridgebury Rd, Ridgefield, CT 06877

About Boehringer Ingelheim Pharmaceuticals Inc


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Boehringer Ingelheim Pharmaceuticals Inc


During the past decade, Boehringer Ingelheim Pharmaceuticals Inc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Boehringer Ingelheim Pharmaceuticals Inc


According to Clinical.Site data, the most researched conditions in "Boehringer Ingelheim Pharmaceuticals Inc" are "Cardiovascular Diseases" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "Boehringer Ingelheim Pharmaceuticals Inc" in a lesser frequency.

Clinical Trials Intervention Types at Boehringer Ingelheim Pharmaceuticals Inc


Most popular intervention types in "Boehringer Ingelheim Pharmaceuticals Inc" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nevirapine" (1 trials), "empagliflozin" (1 trials), "metformin" (1 trials) and "sulfonylurea" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Boehringer Ingelheim Pharmaceuticals Inc


The vast majority of trials in "Boehringer Ingelheim Pharmaceuticals Inc" are 2 trials for "All" genders.

Clinical Trials Status at Boehringer Ingelheim Pharmaceuticals Inc


Currently, there are NaN active trials in "Boehringer Ingelheim Pharmaceuticals Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Boehringer Ingelheim Pharmaceuticals Inc, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Boehringer Ingelheim Pharmaceuticals Inc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".